Autolus Therapeutics PLC at JPMorgan Healthcare Conference (Virtual) Transcript
Okay. Good morning, and thanks again for joining us at the JPMorgan Healthcare Conference. I'm Eric Joseph, senior biotech analyst. Our next presenting company this morning is Autolus, and it's my pleasure to welcome CEO, Christian Itin, to tell us a little bit about the company.
(Operator Instructions)
With that, Christian, thanks again for sharing some of your time with us.
Well, thank you very much for having us. And to be included in this year's presentation at the conference. Welcome, everybody. We'd like to first actually go on Slide 2. Please remember, have a look at our SEC filings, periodic filings, risk factors, look at our forward-looking statements in there, et cetera. And make sure that you're adequately informed.
So with that, I'd like to move to our lead programs and go to Slide #4. And obviously, we're focusing on our AUTO1 program in a disease setting in
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
